Commonwealth Equity Services, LLC Vericel Corp Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Vericel Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 8,282 shares of VCEL stock, worth $474,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,282

Previous 7,513 10.24%

Holding current value

$474,227

Previous $345,000 1.45%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$42.25 - $53.56 $32,490 - $41,187	769 Added 10.24%	8,282 $350,000
Q1 2024 Apr 29, 2024	BUY	$32.52 - $52.33 $24,682 - $39,718	759 Added 11.24%	7,513 $391,000
Q4 2023 Feb 06, 2024	SELL	$30.85 - $37.09 $7,311 - $8,790	-237 Reduced 3.39%	6,754 $241,000
Q3 2023 Oct 23, 2023	SELL	$31.69 - $39.25 $2,376 - $2,943	-75 Reduced 1.06%	6,991 $234,000
Q2 2023 Aug 10, 2023	BUY	$29.0 - $38.37 $1,711 - $2,263	59 Added 0.84%	7,066 $265,000
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $167,116 - $219,599	7,007 New	7,007 $205,000
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $14,567 - $20,955	644 Added 6.89%	9,986 $231,000
Q2 2022 Jul 19, 2022	BUY	$22.88 - $39.45 $1,212 - $2,090	53 Added 0.57%	9,342 $235,000
Q4 2021 Jan 31, 2022	SELL	$35.2 - $52.6 $55,017 - $82,213	-1,563 Reduced 14.4%	9,289 $365,000
Q3 2021 Oct 29, 2021	SELL	$46.35 - $59.75 $7,323 - $9,440	-158 Reduced 1.44%	10,852 $529,000
Q2 2021 Aug 11, 2021	SELL	$47.2 - $67.81 $8,165 - $11,731	-173 Reduced 1.55%	11,010 $578,000
Q1 2021 May 04, 2021	BUY	$30.93 - $59.48 $345,890 - $665,164	11,183 New	11,183 $621,000
Q3 2020 Nov 05, 2020	SELL	$14.68 - $19.12 $159,057 - $207,165	-10,835 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$8.5 - $15.82 $5,100 - $9,492	-600 Reduced 5.25%	10,835 $149,000
Q1 2020 May 11, 2020	SELL	$7.25 - $19.22 $77,937 - $206,615	-10,750 Reduced 48.46%	11,435 $104,000
Q4 2019 Feb 05, 2020	SELL	$13.77 - $19.2 $7,683 - $10,713	-558 Reduced 2.45%	22,185 $386,000
Q3 2019 Oct 30, 2019	BUY	$14.93 - $19.83 $16,990 - $22,566	1,138 Added 5.27%	22,743 $344,000
Q2 2019 Jul 19, 2019	BUY	$15.01 - $18.89 $16,210 - $20,401	1,080 Added 5.26%	21,605 $408,000
Q1 2019 May 13, 2019	SELL	$16.23 - $20.29 $34,083 - $42,609	-2,100 Reduced 9.28%	20,525 $359,000
Q4 2018 Feb 11, 2019	BUY	$10.77 - $18.44 $22,767 - $38,982	2,114 Added 10.31%	22,625 $393,000
Q3 2018 Nov 06, 2018	BUY	$9.1 - $14.8 $70,980 - $115,440	7,800 Added 61.36%	20,511 $290,000
Q2 2018 Jul 31, 2018	BUY	$9.6 - $14.6 $122,025 - $185,580	12,711 New	12,711 $123,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Vericel Corp Transaction History